Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs02491430

Ligand	Ligand name	Chain	PDB	Tanimoto
I3N	1-BENZYL-5-METHOXY-2-METHYL-1H-INDOL-3-YL)-ACETIC ACID	A	1DCY	0.74
6IN	4-(1-BENZYL-3-CARBAMOYLMETHYL-2-METHYL-1H-INDOL-5-YLOXY)-BUTYRIC ACID	A	1DB5	0.7
MT3	2-benzyl-5-{4-[(6,7-dimethoxyquinolin-4-yl)oxy]-3-fluorophenyl}-3-methylpyrimidin-4(3H)-one	A,B	3EFJ	0.73
806	7-[[2-[[1-(1-IMINOETHYL)PIPERIDIN-4-YL]OXY]-9H-CARBOZOL-9-YL]METHYL]NAPHTHALENE-2-CARBOXIMIDAMID	A	1QB9	0.72
AI3	2,3-DIMETHOXY-12H-[1,3]DIOXOLO[5,6]INDENO[1,2-C]ISOQUINOLIN-6-IUM	A,C,D	1TL8	0.83
SIE	SULFAMIC ACID 1-DECYL-2-(4-SULFAMOYLOXYPHENYL)-1H-INDOL-6-YL ESTER	A	2BRP	0.71
EHA	(5-{3-[(6-BENZOYL-1-PROPYL-2-NAPHTHYL)OXY]PROPOXY}-1H-INDOL-1-YL)ACETIC ACID	A	2F4B	0.72
887	N-cyclopropyl-6-[(6,7-dimethoxyquinolin-4-yl)oxy]naphthalene-1-carboxamide	A,B	3B8R	0.71
8PC	2-(2,4-DICHLOROPHENOXY)-5-(PYRIDIN-2-YLMETHYL)PHENOL	A,B	2OP1	0.71
8PC	2-(2,4-DICHLOROPHENOXY)-5-(PYRIDIN-2-YLMETHYL)PHENOL	A,B,C,D	3FNE	0.71
W37	N-(6-{[1-(4-BROMOPHENYL)ISOQUINOLIN-6-YL]OXY}HEXYL)-N-METHYLPROP-2-EN-1-AMINE	A,B,C	1O6H	0.75
253	10,11-dimethoxy-4-methyldibenzo[c,f]-2,7-naphthyridine-3,6-diamine	A	2R7B	0.75
DEH	2,9-dihydroxy-3,10-dimethoxy-5,6-dihydroisoquino[3,2-a]isoquinolinium	A	3GSY	0.82
FLD	BIS-(N-ETHYLPYRIDINIUM-(3-METHOXYCARBAZOLE))HEXANE-1,6-DIAMINE	A,B	154D	0.72
307	6,7-DIMETHYL-3-[(METHYL{2-[METHYL({1-[3-(TRIFLUOROMETHYL)PHENYL]-1H-INDOL-3-YL}METHYL)AMINO]ETHYL}AMINO)METHYL]-4H-CHROMEN-4-ONE	A,C	2AZ5	0.72
PFH	6,7-DIMETHOXY-4-[(3R)-3-(2-NAPHTHYLOXY)PYRROLIDIN-1-YL]QUINAZOLINE	A	2OVV	0.73
BER	BERBERINE	A	3D6Y	0.9
BER	BERBERINE	A,B,D,E	1JUM	0.9
BER	BERBERINE	A,B,D,E	3BTI	0.9
BER	BERBERINE	A	2QVD	0.9
HRM	7-METHOXY-1-METHYL-9H-BETA-CARBOLINE	A	2Z5X	0.73
HRM	7-METHOXY-1-METHYL-9H-BETA-CARBOLINE	A	2Z5Y	0.73
342	(3S)-1-(1,3-BENZODIOXOL-5-YLMETHYL)-3-[4-(1H-IMIDAZOL-1-YL)PHENOXY]PIPERIDINE	A	2ORT	0.72
PU6	8-BENZO[1,3]DIOXOL-,5-YLMETHYL-9-BUTYL-9H-	A	1UY9	0.7
ML1	N-[2-(5-methoxy-1H-indol-3-yl)ethyl]acetamide	A,B	2QX4	0.73
ML1	N-[2-(5-methoxy-1H-indol-3-yl)ethyl]acetamide	A,B	2QX6	0.73
ML1	N-[2-(5-methoxy-1H-indol-3-yl)ethyl]acetamide	A,B	2QWX	0.73
ET0	3-(5-methoxy-1H-indol-3-yl)propanoic acid	A,B	3ET0	0.71
DIT	DITERCALINIUM	A	1D32	0.71
4LG	METHYL (6-{[(2R)-1-(4-{3-[(2-METHOXYBENZYL)OXY]PROPOXY}PHENYL)-6-OXOPIPERAZIN-2-YL]METHOXY}-1H-INDOL-1-YL)ACETATE	A,B	2G27	0.71
P13	N-[2-(3-AMINOPROPOXY)-5-(1H-INDOL-5-YL)BENZYL]-N-(2-PIPERAZIN-1-YLETHYL)AMINE	B	1UTS	0.71
DRY	[(1-{3-[(6-BENZOYL-1-PROPYL-2-NAPHTHYL)OXY]PROPYL}-1H-INDOL-5-YL)OXY]ACETIC ACID	A	2HWQ	0.73
DRD	2-[(1-{3-[(6-BENZOYL-1-PROPYL-2-NAPHTHYL)OXY]PROPYL}-1H-INDOL-4-YL)OXY]-2-METHYLPROPANOIC ACID	A	2HWR	0.73
ET1	3-{5-methoxy-1-[(4-methoxyphenyl)sulfonyl]-1H-indol-3-yl}propanoic acid	A	3ET3	0.72
ET1	3-{5-methoxy-1-[(4-methoxyphenyl)sulfonyl]-1H-indol-3-yl}propanoic acid	A,B	3ET1	0.72
ET1	3-{5-methoxy-1-[(4-methoxyphenyl)sulfonyl]-1H-indol-3-yl}propanoic acid	A,B	3ET2	0.72
7PC	2-[4-(AMINOMETHYL)-2-CHLOROPHENOXY]-5-PYRIDIN-2-YLPHENOL	A,B	2OP0	0.71
232	1,3-DI[[[10-METHOXY-7H-PYRIDO[4,3-C]CARBAZOL-2-IUMYL]-ETHYL]-PIPERIDIN-4-YL]-PROPANE	A	1C9Z	0.71
DTQ	4-[3-HYDROXYANILINO]-6,7-DIMETHOXYQUINAZOLINE	A	1DI8	0.7
YPA	(S)-3-(4-(2-CARBAZOL-9-YL-ETHOXY)-PHENYL)-2-ETHOXY-PROPIONIC ACID	A	1KNU	0.7
CIA	6-BENZO[1,3]DIOXOL-5-YL-2-METHYL-2,3,6,7,12,12A-HEXAHYDRO-PYRAZINO[1',2':1,6]PYRIDO[3,4-B]INDOLE-1,4-DIONE	A,B	1UDU	0.74
CIA	6-BENZO[1,3]DIOXOL-5-YL-2-METHYL-2,3,6,7,12,12A-HEXAHYDRO-PYRAZINO[1',2':1,6]PYRIDO[3,4-B]INDOLE-1,4-DIONE	A	1XOZ	0.74
RO0	1-(3,4-DIMETHOXYBENZYL)-6,7-DIMETHOXY-4-{[4-(2-METHOXYPHENYL)PIPERIDIN-1-YL]METHYL}ISOQUINOLINE	A	2FVJ	0.8
4EA	(1S)-2-(1H-INDOL-3-YL)-1-[({5-[(E)-2-PYRIDIN-4-YLVINYL]PYRIDIN-3-YL}OXY)METHYL]ETHYLAMINE	E	2F7X	0.7